weight loss response to semaglutide in postmenopausal women Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial Did you know? Women on
Description
Reported issues include dosing errors and quality/handling problems (FDA safety communication, updated 2025)
Many believe that medical weight loss is out of reach due to cost or insurance complications
One study reported that GLP-1 is negatively correlated with body mass index (BMI) and that it appears to increase dentate gyrus neurogenesis based on immunostaining images (Weina et al., 2018)
It reaches its nadir around midnight, the amount of which is about a quarter of that in the early morning
this reverses within weeks
